Polymerizable absorbers of UV and high energy visible light

US12196916B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12196916-B2
Application numberUS-202217935677-A
CountryUS
Kind codeB2
Filing dateSep 27, 2022
Priority dateSep 26, 2018
Publication dateJan 14, 2025
Grant dateJan 14, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are polymerizable high energy light absorbing compounds of formula I:wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and X are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.

First claim

Opening claim text (preview).

We claim: 1. An ophthalmic device that is a free radical reaction product of a reactive mixture comprising: one or more monomers suitable for making the ophthalmic device; and a polymerizable high energy light absorbing compound of formula I: wherein R 1 , R 2 and R 3 are independently H, C 1 -C 6 alkyl, C 5 -C 8 cycloalkyl, C 1 -C 6 alkoxy, aryl, aryloxy, halo, or —Y—P g ; X is CR 4 R 5 , O, S, or NR 4 ; R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are independently H, C 1 -C 6 alkyl, C 5 -C 8 cycloalkyl, or —Y—P g ; Y is a linking group; and P g is a polymerizable group comprising (meth)acrylate or (meth)acrylamide, wherein at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 is —Y—P g . 2. The ophthalmic device of claim 1 wherein the compound of formula I contains one —Y—P g group. 3. The ophthalmic device of claim 1 wherein R 1 is Y—P g . 4. The ophthalmic device of claim 1 wherein R 2 and R 3 are each H. 5. The ophthalmic device of claim 1 wherein R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are each H. 6. The ophthalmic device of claim 1 wherein X is CH 2 , O, NH, or NCH 3 . 7. The ophthalmic device of claim 1 wherein Y comprises: C 1 -C 8 alkylene, alkyleneoxy, C 1 -C 8 oxaalkylene, C 1 -C 8 thiaalkylene, C 1 -C 8 alkylene-ester-C 1 -C 8 alkylene, C 1 -C 8 alkylene-amide-C 1 -C 8 alkylene, or C 1 -C 8 alkylene-amine-C 1 -C 8 alkylene. 8. The ophthalmic device of claim 1 wherein the polymerizable high energy light-absorbing compound is selected from the group consisting of 2-((1-amino-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)ethyl methacrylate; N-(2-((1-amino-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)ethyl)methacrylamide; N-(2-((1-amino-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)ethyl)-N-methylmethacrylamide; 2-((5-amino-4-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy)ethyl methacrylate; N-(2-((5-amino-4-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy)ethyl)methacrylamide; N-(2-((5-amino-4-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy)ethyl)-N-methylmethacrylamide; 2-((5-amino-1-methyl-4-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy)ethyl methacrylate; N-(2-((5-amino-1-methyl-4-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy)ethyl)methacrylamide; N-(2-((5-amino-1-methyl-4-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy)ethyl)-N-methylmethacrylamide; 2-((5-amino-4-oxochroman-6-yl)oxy)ethyl methacrylate; N-(2-((5-amino-4-oxochroman-6-yl)oxy)ethyl)methacrylamide; or N-(2-((5-amino-4-oxochroman-6-yl)oxy)ethyl)-N-methylmethacrylamide. 9. The ophthalmic device of claim 1 further comprising a second polymerizable high energy light absorbing compound. 10. The ophthalmic device of claim 9 wherein the second polymerizable high energy light absorbing compound is a UV absorbing compound. 11. The ophthalmic device of claim 10 wherein the UV absorbing compound comprises a compound of formula I, a benzophenone, a benzotriazole, a triazine, a substituted acrylonitrile, a salicyclic acid derivative, a benzoic acid derivative, a cinnamic acid derivative, a chalcone derivative, a dypnone derivative, a crotonic acid derivative, or mixtures thereof. 12. The ophthalmic device of claim 9 wherein the second polymerizable high energy light absorbing compound is 2-(2′-hydroxy-5-methacrylyloxyethylphenyl)-2H-benzotriazole, (Z)-3-hydroxy-1-(naphthalen-2-yl)-3-(4-vinylphenyl) prop-2-en-1-one, 1-(2-amino-3-methoxyphenyl)-2-methylprop-2-en-1-one, or combinations thereof. 13. The ophthalmic device of claim 1 wherein the monomer suitable for making the ophthalmic device comprises a hydrophilic component, a silicone-containing component, or mixtures thereof. 14. The ophthalmic device of claim 1 that is a contact lens, a corneal onlay, a corneal inlay, an intraocular lens, or an overlay lens. 15. The ophthalmic device of claim 1 that is a hydrogel contact lens. 16. A method for making an ophthalmic device, the method comprising: (a) providing a reactive mixture containing a compound of formula I: wherein R 1 , R 2 and R 3 are independently H, C 1 -C 6 alkyl, C 5 -C 8 cycloalkyl, C 1 -C 6 alkoxy, aryl, aryloxy, halo, or —Y—P g ; X is CR 4 R 5 O, S, or NR 4 ; R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are independently H, C 1 -C 6 alkyl, C 5 -C 8 cycloalkyl, or —Y—P g ; Y is a linking group; and P g is a polymerizable group comprising (meth)acrylate or (meth)acrylamide, wherein at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 is —Y—P g ; and one or more device forming monomers, and a radical initiator; and (b) polymerizing the reactive mixture to form the ophthalmic device. 17. A silicone hydrogel contact lens that is a reaction product of a reactive mixture comprising: the polymerizable high energy light absorbing compound of formula I: wherein R 1 , R 2 and R 3 are independently H, C 1 -C 6 alkyl, C 5 -C 8 cycloalkyl, C 1 -C 6 alkoxy, aryl, aryloxy, halo, or —Y—P g ; X is CR 4 R 5 , O, S, or NR 4 ; R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are independently H, C 1 -C 6 alkyl, C 5 -C 8 cycloalkyl, or —Y—P g ; Y is a linking group; and P g is a polymerizable group comprising (meth)acrylate or (meth)acrylamide, wherein at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 is —Y—P g ; and one or more monomers suitable for making an ophthalmic device. 18. The silicone hydrogel contact lens of claim 17 wherein the contact lens has a contact angle of about 70° or less, a water content of at least 25 percent, and an oxygen permeability of at least 80 barrers. 19. The silicone hydrogel contact lens of claim 17 , wherein the reactive mixture further comprises a polyamide, an ultraviolet light absorber, a cross-linking agent, a diluent, or combinations thereof.

Assignees

Inventors

Classifications

  • Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen · CPC title

  • Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur · CPC title

  • Having structure for blocking or reducing amount of light transmitted, e.g. glare reduction · CPC title

  • on to polysiloxanes · CPC title

  • Polysiloxanes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12196916B2 cover?
Described are polymerizable high energy light absorbing compounds of formula I:wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and X are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
Who is the assignee on this patent?
Johnson & Johnson Vision Care, Johsnon & Johnson Vision Care Inc
What technology area does this patent fall under?
Primary CPC classification G02B1/043. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).